Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
REEDS INC (REED)
AMEXConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-11-04
$1.01-0.98%
Close 2026-11-04 · 1-day change
AMEXConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for REED yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve a gross margin of 35% | They aim for a gross margin of 35% by December 2026. | Improving | Gross margin falls below 30% next quarter | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 10, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk turnaround case, not a proven durable growth business. The current long-term thesis is on watch: recent performance is weak, management execution is volatile, and progress toward profitability and wider retail distribution remains limited.
The valuation evidence points to REED being cheap versus peers, but the model has low confidence and the expectations gap is deeply negative. The market appears to recognize substantial business challenges, while the low fragility reading does not remove the risks tied to ongoing losses and listing compliance.
Near term, results may remain under pressure: 2026-Q2 revenue was $7.488M and the operating loss was $4.064M, while recent-quarter misses raise the chance of another weak report. Management has an accepted compliance plan due by November 2027, but its goals for profitable growth and better retail distribution have shown limited progress so far.
The next guidance update is a key near-term swing factor, since a cut could reinforce the pattern of declining expectations. A weakening jobs trend could also pressure cyclical consumer names, while continued strength from sector bellwethers such as KO, PEP, and MNST would provide a more supportive backdrop. Over the multi-year view, the central test is whether REED can improve sales, narrow losses, and meet its listing requirements.
For the next 1 to 3 years, REED remains a high-risk turnaround with weak operating evidence and a meaningful compliance task, partly offset by a supportive sector backdrop. The thesis depends on visible progress in sales and profitability, not just sector momentum. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Reed's can regain compliance with NYSE standards by November 2027. |
| Intact |
| Failure to submit a compliance plan by November 2027 |
Compliance plan not yet due (deadline Nov 2027) News feed empty; recent events show capital allocation and a prior delisting notice, but no new regulatory failure or stalled recovery indicators. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “As previously announced, in connection with its non-compliance with Section 1003(a)(ii) and Section 1003(a)(iii) of the Company Guide, the Company must submit a plan (the “Plan”) to the NYSE American advising of actions it has taken or will take to regain compliance with the continued listing standards by November 29, 2027.” “On August 12, 2026, NYSE American determined to accept the Plan, and the Company will be subject to periodic reviews, including quarterly monitoring for compliance with the Plan.” Delivery assessment Nov 4, 2026 |
Regain shelf space and increase retail distribution | Sales growth could return with better retail distribution. | Intact | Sales decline continues over the next year | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “The Company’s beverages are now sold in over 32,000 stores nationwide.” Delivery assessment Nov 4, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.69 → $-0.44 · observed estimates
$0.04B → $0.04B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-03 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-04 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-05 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-06 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-08 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-09 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-10 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-12 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-13 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-14 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-15 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-16 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-17 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-18 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-19 | $-0.69 | $37,002,400 | 1 / 1 |
| 2026-08-20 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-21 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-22 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-23 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-24 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-25 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-26 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-27 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-28 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-29 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-30 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-08-31 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-01 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-02 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-03 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-04 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-05 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-06 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-07 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-08 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-09 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-10 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-11 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-12 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-13 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-14 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-15 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-16 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-17 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-18 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-19 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-20 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-21 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-22 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-23 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-24 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-25 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-26 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-27 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-28 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-29 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-09-30 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-01 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-02 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-03 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-04 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-05 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-06 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-07 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-08 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-09 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-10 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-11 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-12 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-13 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-14 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-15 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-16 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-17 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-18 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-19 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-20 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-21 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-22 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-23 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-24 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-25 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-26 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-27 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-28 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-29 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-30 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-10-31 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-11-01 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-11-02 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-11-03 | $-0.44 | $40,612,700 | 1 / 1 |
| 2026-11-04 | $-0.44 | $40,612,700 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.